Cipro
Product Images NDC 67296-2065

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cipro (NDC 67296-2065). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ciprofloxacin Chemical Structure (Ciprohc 01)

Chemical structure diagram of the active ingredient in CIPRO HC, showing the molecular arrangement with labeled atoms including fluorine, nitrogen, oxygen, and a carboxyl group. The structure includes a hydrochloride and water molecule as indicated in the formula.*

FDA Label Image

Hydrocortisone Chemical Structure (Ciprohc 02)

Chemical structure diagram depicting the molecular structure of the active ingredient in CIPRO HC, as submitted in the FDA Structured Product Labeling.*

FDA Label Image

Principal Display Panel Ndc 0078-0855-26 Cipro® Hc Otic (ciprofloxacin 0.2% Hci And Hydrocortisone 1% Otic Suspension) Not For Ophthalmic Or Oral Use Rx O (Ciprohc 03)

Packaging label for CIPRO HC OTIC, an otic suspension containing ciprofloxacin 0.2% HCl and hydrocortisone 1%. The label indicates a 10 mL bottle, labeled as Rx only and not for ophthalmic or oral use. Labeler is Novartis, with manufacturing and distribution details noted. Storage and usage cautions are also provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.